Sio Gene Therapies Inc.
NASDAQ:SIOX
0.415 (USD) • At close July 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 63.729 | 118.986 | 80.752 | 106.999 | 154.337 | 212.573 | 276.251 | 0 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 63.729 | 118.986 | 80.752 | 106.999 | 154.337 | 212.573 | 276.251 | 0 |
| Net Receivables
| 1.609 | 5.999 | 1.707 | 1.726 | 1.751 | 0.658 | 0.97 | 0 |
| Inventory
| 0 | -5.999 | -1.707 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 6.398 | 13.347 | 4.678 | 5.859 | 2.174 | 6.457 | 4.865 | 1.108 |
| Total Current Assets
| 71.736 | 132.333 | 85.43 | 114.584 | 158.262 | 219.688 | 282.086 | 1.108 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 3.344 | 1.63 | 2.333 | 1.278 | 2.524 | 0.142 | 0.089 | 0.009 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 5.871 | 5.871 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 2.709 | 0.323 | 0 |
| Other Non-Current Assets
| 0 | 1.184 | 0.046 | 0.973 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets
| 3.344 | 2.814 | 8.25 | 8.122 | 2.524 | 2.851 | 0.412 | 0.009 |
| Total Assets
| 75.08 | 135.147 | 93.68 | 122.706 | 160.786 | 222.539 | 282.498 | 1.117 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 3.984 | 1.341 | 4.412 | 1.698 | 3.949 | 8.551 | 0.622 | 0.403 |
| Short Term Debt
| 0.786 | 0.311 | 16.312 | 21.182 | 9.753 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | -21.182 | -9.753 | 0 | 0 | 0 |
| Other Current Liabilities
| 8.232 | 9.196 | 11.319 | 41.801 | 42.626 | 37.715 | 15.133 | 3.465 |
| Total Current Liabilities
| 13.002 | 10.848 | 32.043 | 43.499 | 46.575 | 46.266 | 15.755 | 3.868 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 1.73 | 0.932 | 0.079 | 22.994 | 42.925 | 51.436 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
| Total Non-Current Liabilities
| 1.73 | 0.932 | 0.079 | 22.994 | 42.925 | 51.436 | 0 | 5 |
| Total Liabilities
| 14.732 | 11.78 | 32.122 | 66.493 | 89.5 | 97.702 | 15.755 | 8.868 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.001 | 0.001 | 0 | 0 | 0.001 | 0.001 | 0.001 | 0.001 |
| Retained Earnings
| -862.956 | -791.069 | -758.644 | -686.016 | -556.951 | -335.143 | -154.192 | -21.047 |
| Accumulated Other Comprehensive Income/Loss
| 0.337 | 0.335 | -0.055 | 0.911 | 0.126 | 0.378 | 0 | 0 |
| Other Total Stockholders Equity
| 922.966 | 914.1 | 820.257 | 741.318 | 628.11 | 459.979 | 420.934 | 13.295 |
| Total Shareholders Equity
| 60.348 | 123.367 | 61.558 | 56.213 | 71.286 | 124.837 | 266.743 | -7.751 |
| Total Equity
| 60.348 | 123.367 | 61.558 | 56.213 | 71.286 | 124.837 | 266.743 | -7.751 |
| Total Liabilities & Shareholders Equity
| 75.08 | 135.147 | 93.68 | 122.706 | 160.786 | 222.539 | 282.498 | 1.117 |